Basis and clinical research of 125I seed implantation for curing nasopharyngeal carcinoma

Abstract

Ma Xuan, Li Xiaojiang. Basis and clinical research of 125I seed implantation for curing nasopharyngeal carcinoma[J]. Journal of International Oncology, 2014, 41(8): 659-661.

［1］ Xu T, Tang J, Gu M, et al. Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge［J］. Curr Oncol, 2013, 20(5): 406-419. ［2］张康. 放射性125I粒子对人鼻咽癌细胞的杀伤效应的实验研究［D］. 昆明: 昆明医科大学, 2012. ［3］张汝森, 戴丽冰, 黎庆梅, 等. 125I低剂量率照射对鼻咽癌细胞 CNE2的杀伤效应［J］. 广东医学, 2011, 32（21): 2789-2791. ［4］ Tian Y, Xie Q, Tian Y, et al. Radioactive 125I seed inhibits the cell growth, migration, and invasion of nasopharyngeal carcinoma by triggering DNA damage and inactivating VEGFA/ERK signaling［J］. PLoS One, 2013, 8(9): e74038. ［5］李彦, 罗开元. 125I粒子内放射治疗恶性肿瘤的分子生物学机制研究进展［J］. 医学综述, 2011, 17(18): 2746-2748. ［6］ Li HX, Zhao J, Shen K, et al. Comparison of Iodine125 seeds implantation and afterloading radiotherapy in murine models of human cervical cancer［J］. Arch Gynecol Obstet, 2014, 289(5): 1101-1106. ［7］ Stoker SD, van Diessen JN, de Boer JP, et al. Current treatment options for local residual nasopharyngeal carcinoma［J］. Curr Treat Options Oncol, 2013, 14(4): 475-491. ［8］ Jiang YL, Meng N, Wang JJ, et al. CTguided iodine125 seed permanent implantation for recurrent head and neck cancers［J］. Radiat Oncol, 2010, 30(5): 68. ［9］熊锐华, 田秀荣, 王鸿智, 等. CT引导下125I粒子植入治疗鼻咽癌根治性放疗后鼻咽部病灶残留［J］. 现代中西医结合杂志, 2011, 20(3): 323-324. ［10］谢岳云, 伍靖武, 王鸿智, 等. CT引导下125I粒子植入治疗鼻咽癌放疗后残留病灶的疗效［J］. 肿瘤, 2009, 29(12): 1170-1172. ［11］湛永滋, 黄昌杰, 黄剑峰. 鼻内镜下125I粒子植入治疗鼻咽癌放疗后鼻咽部残留病灶［J］. 中国内镜杂志, 2008, 14(5): 485-490. ［12］卢泰祥, 韩非, 李嘉欣. 复发鼻咽癌临床研究进展［J］. 中国癌症杂志, 2008, 18(9): 661-666. ［13］韩非, 卢泰祥. 复发鼻咽癌的挽救治疗［J］. 肿瘤学杂志, 2009, 15(7): 606-608. ［14］张启周, 栗国梁, 黄海福. 125I放射性粒子植入联合化疗治疗复发鼻咽癌的临床观察［J］. 肿瘤学杂志, 2013, 19(8): 636-638. ［15］ Zhang F, Wu K, Gao F, et al. Refractory nasopharyngeal carcinoma: positron emission tomography combined with computed tomographyguided 125I seed implantation therapy after repeated traditional radiochemotherapy［J］. Otolaryngol Head Neck Surg, 2013, 149(3): 417-423. ［16］张海. 鼻咽癌治疗后远处转移的相关因素探讨［D］. 重庆: 第三军医大学, 2007. ［17］王成涛, 曹卡加, 李茵, 等. 鼻咽癌远处转移的预后因素分析［J］. 癌症, 2007, 26(2): 212-215. ［18］黄金华, 顾仰葵, 张亮, 等. 鼻咽癌肺转移瘤125I放射性粒子植入疗效分析［J］. 国际肿瘤学杂志, 2006, 33(3): 233-235. ［19］ Rosenblatt E, AbdelWahab M, ElGantiry M, et al. Brachytherapy boost in locoregionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency［J］. Radiat Oncol, 2014, 9(1): 67.

[1]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[2]	Gu Anqin, Long Jinhua, Jin Feng.Clinical research progress of immunotherapy for nasopharyngeal carcinoma[J]. Journal of International Oncology, 2023, 50(5): 299-303.
[3]	Chen Fangming, Cai Yuanyuan, Li Han, Wang Xiaoli, Kan Hongxing, Li Yang, Hao Furong, Wang Mingchen.Prognostic differences of nasopharyngeal carcinoma patients treated with intensity-modulated radiothe-rapy with different T staging of the seventh and eighth edition of the UICC staging system[J]. Journal of International Oncology, 2021, 48(9): 515-522.
[4]	Peng Ya, Liu An, Liu Huowang.Inhibitory effect and mechanism of PSD-007 photodynamic therapy on human nasopharyngeal carcinoma transplanted tumors in nude mice[J]. Journal of International Oncology, 2021, 48(3): 136-142.
[5]	Zhu Lei, Huang Jianbo.Effects of Epstein-Barr virus DNA load and different treatment methods on the therapeutic effect and prognosis of stage Ⅲ nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(2): 74-79.
[6]	Luo Wenxiao, Wu Dehua, Cai Longmei.Prognostic values of immune efficacy biomarkers in the treatment of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(12): 743-746.
[7]	Yang Minghui, Jin Feng.Value of 3D-ASL, MRS and DTI in the diagnosis and treatment of radiation-induced temporal lobe injury of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2020, 47(9): 550-554.
[8]	Yang Chao, Wang Jianbo, Zhang Juhong, Wang Jialong.Overexpression of miR-125 inhibits proliferation and invasion of nasopharyngeal carcinoma cells by down-regulating FGF-2[J]. Journal of International Oncology, 2020, 47(5): 257-263.
[9]	Shen Jianjun.Treatment of local recurrenct nasopharyngeal carcinoma after radiotherapy[J]. Journal of International Oncology, 2020, 47(4): 227-230.
[10]	Zhou Yuanyuan, Li Jing.Clinical practice value of hematological inflammation biomarkers in nasopharyngeal carcinoma[J]. Journal of International Oncology, 2019, 46(8): 492-495.
[11]	Zhou Ping, Chen Weisi, Zhang Shuang, Lin Bing, Pan Tao, Liu Sha.Observation of efficacy of paclitaxel with concurrent radiotherapy in the treatment for nasopharyngeal carcinoma patients with liver metastasis[J]. Journal of International Oncology, 2019, 46(6): 327-330.
[12]	CHEN Jiong-Yu, ZHUANG Yi-Xuan, ZHUANG Shan-Shan, PENG Lin.Effects of osthole on the proliferation, invasion and migration of nasopharyngeal carcinoma cells CNE2[J]. Journal of International Oncology, 2018, 45(8): 453-459.
[13]	LAI Shi-Jia, ZHAO De-An, SUN Yong-Ming.Expression and clinical significance of serum microRNA663 in nasopharyngeal carcinoma patients[J]. Journal of International Oncology, 2018, 45(8): 460-464.
[14]	Huang Ting, Song Xuewei, An Shufen, Wang Zhibin, Liao Hehe.Expressions of MDR-1 and P-gp in human nasopharyngeal squamous cell carcinoma CNE1 cell line after X-ray exposure[J]. Journal of International Oncology, 2018, 45(6): 321-324.
[15]	Huang Can, Chen Qiuyan, Zuo Feifei, Peng Chuan, Zhong Shaobin, Mai Haiqiang, Chen Mingyuan, Zou Ruhai.Diagnostic value of lymph node EBV-DNA detection in cervical lymph node metastasis of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2018, 45(3): 143-147.

Basis and clinical research of 125I seed implantation for curing nasopharyngeal carcinoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments